Medicine & Life Sciences
Atrophy
100%
Cognitive Dysfunction
94%
Costs and Cost Analysis
71%
Salaries and Fringe Benefits
69%
Brain
56%
Budgets
50%
Population
44%
Names
36%
Occupational Groups
27%
Biomarkers
24%
Alzheimer Disease
24%
Research Personnel
17%
Organized Financing
15%
Financial Management
14%
Alleles
14%
formycin diphosphate
9%
Apolipoproteins A
9%
United States Dept. of Health and Human Services
9%
Giardia
8%
Serum
8%
Cryptosporidium
8%
Lipids
8%
Glucose
8%
Manuscripts
7%
Interleukin-13
7%
Systems Analysis
7%
Economic Inflation
7%
Interleukin-5
7%
Apolipoproteins B
7%
Granulocyte-Macrophage Colony-Stimulating Factor
6%
Hepatitis C
6%
Genomics
6%
Thyroid Hormones
6%
oxidized low density lipoprotein
6%
Cytomegalovirus
6%
Infections
6%
Brain Diseases
6%
Interleukin-4
5%
Immunoglobulin E
5%
LDL Cholesterol
5%
Interleukin-10
5%
Interleukin-2
5%
Immunoglobulin M
5%
C-Reactive Protein
5%
Salts
5%
Cost-Benefit Analysis
5%
Fatty Acids
5%
Parasites
5%
Thyroid Gland
5%
Immune System
5%
Datasets
5%
Cognition
5%